# US 2006/0155334 A1 · Methods and systems for reducing discomfort from cardiac defibrillation shocks

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0155334 A1
- Document ID: US20060155334A1
- Status: Published application
- Kind: A1
- Application number: 10/388,211
- Filed: 2003-03-13
- Published: 2006-07-13
- Earliest claimed: 2003-03-13
- Assignees: The UAB Research Foundation
- Inventors: Raymond Ideker; Gregory Walcott
- Web page: https://patentgrep.com/patent/US20060155334A1

## CPC

- A61N 1/3956: {Implantable devices for applying electric shocks to the heart, e.g. for cardioversion}
- A61N 1/395: {for treating atrial fibrillation}
- H10W 72/012: {of bump connectors, dummy bumps or thermal bumps}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- H10W: GENERIC PACKAGES, INTERCONNECTIONS, CONNECTORS OR OTHER CONSTRUCTIONAL DETAILS OF DEVICES COVERED BY CLASS H10

## Abstract

Methods, systems and computer program products for combining atrial defibrillation treatment techniques include techniques for reducing the discomfort associated with defibrillation and/or reducing the defibrillation threshold. Techniques include timing the defibrillation shock to reduce discomfort based on a sensed signal, giving the shock relatively early during atrial fibrillation, therapeutic drugs, administering more than one shock in succession, pacing the heart before, after, or during the defibrillation shock or shocks, and placing the shock electrodes in locations that may reduce discomfort.

## Claims

### Claim 1

A method for reducing discomfort associated with atrial defibrillation comprising:
determining a time during the cardiac cycle at which atrial blood volume is reduced; and
delivering a defibrillation shock to the heart at the time at which atrial blood volume is reduced.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the determining step comprises detecting the cardiac cycle.

### Claim 3 (depends on 1)

The method according to claim 1, further comprising:
administering a therapeutic drug selected from the group consisting of a calcium channel blocker, a calmodulin blocker, a calmodulin kinase inhibitor and an antiarrhythmic drug to the subject at a time and in an amount effective to decrease the strength of the shock required to treat the fibrillation.

### Claim 4 (depends on 1)

The method according to claim 1, further comprising:
delivering a preparatory shock to the atria of the heart a subject experiencing arrhythmia; and then
delivering the defibrillation shock to the atria after the preparatory shock during contraction of the atria, wherein the preparatory shock has a strength less than the defibrillation shock.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the time between the preparatory shock and the defibrillation shock is between about 50 and about 500 ms.

### Claim 6 (depends on 4)

The method according to claim 4, wherein the voltage of the preparatory shock is between about 5 and 100V and the voltage of the defibrillation shock is between about 10 and about 200V.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the defibrillation shock is less than about 34 joules.

### Claim 8 (depends on 1)

The method according to claim 1, wherein a leading edge voltage of the defibrillation threshold shock is reduced by at least 20% compared to a defibrillation shock delivered to the heart at the time at which atrial blood volume is not reduced.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the defibrillation threshold shock is reduced by at least 40% in energy compared to a defibrillation shock delivered to the heart at the time at which atrial blood volume is not reduced.

### Claim 10 (depends on 1)

The method according to claim 1, further comprising:
positioning first and second defibrillation electrodes in operable association with the heart of a subject, the first and second defibrillation electrodes defining a potential gradient field in the heart, the potential gradient field including a region of the heart to be defibrillated;
positioning a third electrode in the gradient field between the first and second electrodes; and
wherein the defibrillation shock further comprises:
sequentially delivering (a) a first defibrillation shock between the first and third electrode and (b) a second defibrillation shock between the second and third electrodes; with the first and second defibrillation shocks together effective to defibrillate the heart; and
wherein the voltage for each of the first and second defibrillation shocks is less than the defibrillation shock threshold necessary for a single defibrillation shock delivered between the first and second electrodes.

### Claim 11 (depends on 10)

A method according to claim 10, wherein the first and second defibrillation shocks are delivered simultaneously.

### Claim 12 (depends on 10)

A method according to claim 10, wherein the first and second defibrillation shocks are delivered sequentially.

### Claim 13 (depends on 10)

A method according to claim 10, wherein each of the first and second defibrillation shocks are less than about four Joules in magnitude.

### Claim 14 (depends on 1)

The method according to claim 1, further comprising:
determining the fibrillation cycle length; and
after delivering the defibrillation shock at the time at which atrial blood volume is reduced, delivering a second defibrillation shock to the heart, wherein the second defibrillation shock is spaced apart from the defibrillation shock by about 80% to about 90% of the time of the fibrillation cycle length.

### Claim 15 (depends on 14)

The method according to claim 14, further comprising:
delivering a third defibrillation shock spaced apart from the second defibrillation shock by about the time of the fibrillation cycle length.

### Claim 16

A cardiac system for treating arrhythmia in a subject in need thereof, comprising:
an arrhythmia detector configured to determine when a cardiac arrhythmia is occurring and to detect the cardiac cycle from electrical activity sensed from the heart of a subject;
a controller operatively associated with the detector; and
a shock generator operatively associated with the controller; wherein the controller is configured to direct the shock generator to deliver a defibrillation shock to one or more electrodes placed in operative association with the heart at a time during the cardiac cycle at which atrial blood volume is reduced.

### Claim 17 (depends on 16)

The system of claim 16, wherein the controller is configured to communicate instructions to the shock generator to deliver a preparatory shock to the atria of the heart and then the defibrillation shock to the atria at a time sufficient to allow contraction of the atria, wherein the preparatory shock has a strength less than the defibrillation shock.

### Claim 18 (depends on 16)

The system of claim 16, wherein the controller is configured to deliver the therapeutic drug between about ten minutes prior to the defibrillation shock to contemporaneous with the defibrillation shock so that the strength of the shock is decreased as compared to the shock required to treat the arrhythmia in the absence of administration of the therapeutic drug.

### Claim 19 (depends on 16)

The system of claim 16, further comprising an injector operatively associated with the controller to administer one or more therapeutic drugs selected from the group consisting of a calcium channel blocker, a calmodulin blocker, a calmodulin kinase inhibitor, and an antiarrhythmic drug to the subject.

### Claim 20 (depends on 16)

The system of claim 16, wherein the system comprises an internal device.

### Claim 21 (depends on 16)

The system of claim 16, wherein the system comprises an external device.

### Claim 22 (depends on 16)

The system of claim 16, wherein the therapeutic electric shock is not greater than 34 joules.

### Claim 23 (depends on 16)

The system of claim 16, further comprising:
a first catheter configured for insertion into the right atrium of the heart;
a first atrial defibrillation electrode carried by the catheter and positioned at the atrial septum of the heart;
a second atrial defibrillation electrode spaced apart from the first atrial defibrillation electrode, the first and second atrial defibrillation electrodes defining an potential gradient field in a cardiac region to be defibrillated;
a third atrial defibrillation electrode configured for positioning in the potential gradient field between the first and second electrodes; and
wherein the controller is configured to communicate instructions to the shock generator to deliver a shock to the atria of the heart through the first and second atrial defibrillation electrodes and then sequentially delivering (a) a first defibrillation shock between the first and third electrode and (b) a second defibrillation shock between the second and third electrodes; with the first and second defibrillation shocks together effective to defibrillate the heart at a time during contraction of the atria.

### Claim 24 (depends on 16)

The system of claim 16, wherein the controller is further configured to determine time of the fibrillation cycle length, and after the delivery of the defibrillation shock at the time at which atrial blood volume is reduced, to deliver a second defibrillation shock to the heart, wherein the second defibrillation shock is spaced apart from the defibrillation shock by about 80% to about 90% of the time of the fibrillation cycle length.

### Claim 25 (depends on 24)

The system of claim 24, wherein the controller is further configured to deliver a third defibrillation shock spaced apart from the second defibrillation shock by about the time of the fibrillation cycle length.

### Claim 26

A method for reducing discomfort associated with atrial defibrillation comprising:
delivering a biphasic waveform defibrillation shock having a first ascending phase and a second phase of opposite polarity, the first ascending phase maintaining an effective voltage greater than about 50 to about 80% of the peak voltage for a duration greater than 0.5 to about 1.0 ms.

### Claim 27 (depends on 26)

A method according to claim 26, wherein the delivering step further comprises:
determining a time during the cardiac cycle at which atrial blood volume is reduced; and
delivering the biphasic waveform defibrillation shock to the heart at a time at which atrial blood volume is reduced.

### Claim 28 (depends on 26)

A method according to claim 26, further comprising:
delivering a preparatory shock to the atria of the heart a subject experiencing arrhythmia; and
delivering the biphasic waveform defibrillation shock to the atria after the first shock during contraction of the atria, wherein the preparatory shock has a strength less than the biphasic waveform defibrillation shock.

### Claim 29 (depends on 26)

A method according to claim 26, further comprising:
positioning first and second defibrillation electrodes in operable association with the heart of a subject, the first and second defibrillation electrodes defining a gradient field in the heart, the potential gradient field including a region of the heart to be defibrillated; and
positioning a third electrode in the gradient field between the first and second electrodes.

### Claim 30 (depends on 29)

A method according to claim 29, the biphasic waveform defibrillation shock further comprises:
sequentially delivering (a) a first biphasic waveform defibrillation shock between the first and third electrode and (b) a second biphasic waveform defibrillation shock between the second and third electrodes; wherein the first and second defibrillation shocks are together effective to defibrillate the heart.

### Claim 31 (depends on 26)

A method according to claim 26, further comprising:
administering a therapeutic drug selected from the group consisting of a calcium channel blocker, a calmodulin blocker, a calmodulin kinase inhibitor and an antiarrhythmic drug to the subject at a time and in an amount effective to decrease the strength of the shock required to treat the fibrillation.

### Claim 32 (depends on 31)

A method according to claim 31, wherein the controller is configured to deliver the therapeutic drug at the time with the defibrillation shock so that the strength of the shock is decreased as compared to the shock required to treat the arrhythmia in the absence of administration of the therapeutic drug.

### Claim 33 (depends on 26)

A method according to claim 26, wherein the second phase has a duration greater than about 1 ms.

### Claim 34 (depends on 26)

A method according to claim 26, wherein the second phase has a duration greater than about 5 ms.

### Claim 35 (depends on 26)

A method according to claim 26, wherein the second phase has a duration between about 0.5 and about 1 ms.

### Claim 36 (depends on 26)

A method according to claim 26, wherein the first phase is followed by an interval in which no shock occurs.

### Claim 37 (depends on 36)

A method according to claim 36, wherein the interval has a duration between about 1 and about 3 ms.

### Claim 38 (depends on 36)

A method according to claim 36, wherein the first phase has a duration between about 5 and about 15 ms, the interval has a duration about 2 ms, and the second phase has a duration between about 1 and about 5 ms.

### Claim 39 (depends on 26)

A method according to claim 26, wherein the first phase comprises an ascending shape followed by a square wave.

### Claim 40 (depends on 39)

A method according to claim 39, wherein the square wave has a duration between about 1 to 3 ms.

### Claim 41 (depends on 39)

A method according to claim 39, wherein the first phase is followed immediately by the second phase.

### Claim 42 (depends on 26)

A method according to claim 26, wherein the first phase comprises an exponentially increasing waveform.

### Claim 43 (depends on 26)

A method according to claim 26, further comprising:
determining the time of the fibrillation cycle length; and
after delivering the biphasic waveform defibrillation shock, delivering a second defibrillation shock to the heart, wherein the second defibrillation shock is spaced apart from the biphasic waveform defibrillation shock by about 80% to about 90% of the time of the fibrillation cycle length.

### Claim 44 (depends on 43)

A method according to claim 43, further comprising:
delivering a third defibrillation shock spaced apart from the second defibrillation shock by about the time of the fibrillation cycle length.

### Claim 45

A cardiac system for treating arrhythmia in a subject in need thereof, comprising:
an arrhythmia detector configured to determine when a cardiac arrhythmia is occurring from electrical activity sensed from the heart of a subject;
a controller operatively associated with the detector; and
a shock generator operatively associated with the controller; the controller configured to direct the shock generator to deliver a biphasic waveform shock through one or more defibrillation electrodes placed in operative association with the heart, the biphasic waveform shock having a first ascending phase and a second phase of opposite polarity, the first ascending phase maintaining an effective voltage greater than about 50 to about 80% of the peak voltage for a duration greater than 0.5 to about 1.0 ms.

### Claim 46 (depends on 45)

A system according to claim 45, further comprising:
a first catheter configured for insertion into the right atrium of the heart without extending into the right ventricle of the heart;
a second atrial defibrillation electrode spaced apart from the first atrial defibrillation electrode, the first and second atrial defibrillation electrodes defining an potential gradient field in a cardiac region to be defibrillated; and
a third atrial defibrillation electrode configured for positioning in the potential gradient field between the first and second electrodes.

### Claim 47 (depends on 46)

A system according to claim 46, wherein the controller is configured to communicate instructions to the shock generator to deliver a shock to the atria of the heart through the first and second atrial defibrillation electrodes and then sequentially delivering (a) a first defibrillation shock between the first and third electrode and (b) a second defibrillation shock between the second and third electrodes; with the first and second defibrillation shocks together effective to defibrillate the heart at a time during contraction of the atria.

### Claim 48 (depends on 45)

A system according to claim 45, further comprising an injector operatively associated with the controller to administer a therapeutic drug selected from the group consisting of a calcium channel blocker, a calmodulin blocker, a calmodulin kinase inhibitor, and an antiarrhythmic drug to the subject.

### Claim 49 (depends on 45)

A system according to claim 45, wherein the second phase has a duration greater than about 2 ms.

### Claim 50 (depends on 45)

A system according to claim 45, wherein the second phase has a duration greater than about 5 ms.

### Claim 51 (depends on 45)

A system according to claim 45, wherein the second phase has a duration between about 0.5 and about 1 ms.

### Claim 52 (depends on 45)

A system according to claim 45, wherein the first phase is followed by an interval in which no shock occurs.

### Claim 53 (depends on 52)

A system according to claim 52, wherein the interval has a duration between about 1 and about 3 ms.

### Claim 54 (depends on 52)

A system according to claim 52, wherein the first phase has a duration between about 5 and about 15 ms, the interval has a duration between about 0.5 and about 2 ms, and the second phase has a duration between about 1 and about 5 ms.

### Claim 55 (depends on 45)

A system according to claim 45, wherein the first phase comprises an ascending shape followed by a square wave.

### Claim 56 (depends on 55)

A system according to claim 55, wherein the square wave has a duration between about 1 to 3 ms.

### Claim 57 (depends on 55)

A system according to claim 55, wherein the first phase is followed immediately by the second phase.

### Claim 58 (depends on 45)

A system according to claim 45, wherein the first phase comprises an exponentially increasing waveform.

### Claim 59 (depends on 45)

A system according to claim 45, wherein the controller is configured to determine the time of the fibrillation cycle length, and after delivering the biphasic waveform defibrillation shock, to deliver a second defibrillation shock to the heart, wherein the second defibrillation shock is spaced apart from the defibrillation shock by about 80% to about 90% of the time of the fibrillation cycle length.

### Claim 60 (depends on 59)

A system according to claim 59, wherein the controller is configured to deliver a third defibrillation shock spaced apart from the second defibrillation shock by about the time of the fibrillation cycle length.

### Claim 61

A method for reducing discomfort associated with atrial defibrillation comprising:
determining the time of the fibrillation cycle length; and
delivering a first defibrillation shock to the heart;
delivering a second defibrillation shock to the heart, wherein the second defibrillation shock is spaced apart from the defibrillation shock by about 80% to about 90% of the time of the fibrillation cycle length;
delivering a third defibrillation shock to the heart, wherein the third defibrillation shock is spaced apart from the second defibrillation shock by about the time of the fibrillation cycle length.

### Claim 62

A method for reducing discomfort associated with atrial defibrillation comprising:
selectively administering at least two of a plurality of treatment techniques, the treatment techniques comprising:
(a) selecting and administering a shock waveform that requires a reduced shock energy, voltage, or current;
(b) selecting and administering a shock waveform or sequence of waveforms that is intrinsically less painful;
(c) timing a defibrillation shock based on a sensed signal of the fibrillation electrical complex;
(d) administering a defibrillation shock at the onset of fibrillation;
(e) administering drugs that lower the defibrillation threshold;
(f) administering drugs that decrease the discomfort associated with the shock;
(g) administering a plurality of shocks in succession;
(h) performing pacing before or after the defibrillation shock; and
(i) delivering one shock, sequential shocks, or overlapping shocks from three or more electrodes.
